Related Experiment Video
Updated: May 19, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment
Umut Kefeli1, Mahmut Emre Yildirim, Dincer Aydin
1Department of Medical Oncology, Dr. Lutfi Kirdar Kartal Education and Research Hospital, Istanbul, Turkey. ukefeli@yahoo.com
Context:
Netrin-1 is found to be elevated and usable as a diagnostic biomarker in many human cancers.
Objectives:
We evaluated serum Netrin-1 concentrations in patients with advanced gastric cancer compared with those in a healthy group.
Material And Methods:
Thirty patients with advanced gastric cancer and thirty healthy people were included in the study. Serum netrin-1 concentrations were measured by quantitative ELISA method in both groups.
Results:
The mean serum Netrin-1 concentrations were found to be significantly higher in patients with gastric cancer than in healthy controls. The mean serum Netrin-1 concentrations were found to be significantly higher in patients with gastric cancer before the beginning of chemotherapy when compared after the completion of third cycle.
Discussion And Conclusion:
Our results indicated that netrin-1 concentrations elevated in advanced gastric cancer compared to a healthy control group and netrin-1 concentrations decreased with chemotherapy.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Targeted Cancer Therapies
There are several types of targeted therapies against specific...